Who invested in Cardurion Pharmaceuticals?
Cardurion Pharmaceuticals's investors include New Enterprise Associates, Polaris Partners, Fidelity, Digitalis Ventures and Blue Owl, and 1 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$260Mraised across 1 round since 2024, from 1 source
Source recordedSEC filing: $260M sold, first sale Jul 2024
From Cardurion Pharmaceuticals's own website: 4 on the team.
Cardurion Pharmaceuticals's investors include New Enterprise Associates, Polaris Partners, Fidelity, Digitalis Ventures and Blue Owl, and 1 more on record.
Cardurion Pharmaceuticals has raised $260M across 1 round since 2024.
Cardurion Pharmaceuticals's most recent round was a Series B of $260M in Jul 2024.
Its most recent round, $260M in Jul 2024, is also its largest on record.
Cardurion Pharmaceuticals's first round on record, in Jul 2024, was backed by New Enterprise Associates, Polaris Partners and Fidelity and 3 others.
Cardurion Pharmaceuticals's latest named round is a Series B, in Jul 2024.
Cardurion Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.